Phase I Study With Expansion Cohorts To Assess The Safety, Tolerability, And Activity Of Oral Paclitaxel (Opac) Plus Encequidar (E) In Combination With Pembrolizumab (Pem) In Subjects With Advanced Solid Malignancies

W. W. Ma,P. Singh, R. Manochakian, H. Yoon, A. A. Adjei,Y. Lou,D. Cutler, D. Landers,W-K. Chan,J. Zhi, R. Kwan

ANNALS OF ONCOLOGY(2021)

引用 1|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要